Loss-of-function mutations in subunits of the NAPDH oxidase cause chronic granulomatous disease (CGD)55, which is characterized by the formation of granulomas throughout the body due to the inability of phagocytes to kill the ingested pathogens. Here, FMO5 is linked to chronic granulomatous disease.